← Open Payments lookup

ROBERT HAMILTON: Open Payments

NPI 1619412012 · HARRIS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,581 in 162 payments from 15 companies in 2025. Trend: 2023 $648 · 2024 $2,188 · 2025 $2,581

Food & beverage: $2,581
CompanyPaymentsAmount
ABBVIE INC.86$1,147
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$449
Supernus Pharmaceuticals, Inc.11$219
Otsuka America Pharmaceutical, Inc.17$181
Teva Pharmaceuticals USA, Inc.5$124
Neurocrine BioSciences, Inc.3$86
Alkermes, Inc.3$78
Janssen Pharmaceuticals, Inc2$56
Lundbeck LLC3$51
Axsome Therapeutics, Inc.2$46

Products named: VRAYLAR, CAPLYTA, Qelbree, REXULTI, AUSTEDO XR, INGREZZA, SPRAVATO, LYBALVI.

Industry payments across NY — which companies pay providers there.